How Will Walgreen (WAG) Stock Be Impacted By Its June Sales Increase?

NEW YORK (TheStreet) --Shares of Walgreen Co. (WAG) are up slightly by 0.63% to $73.50 in pre-market trading on Thursday after the company reported an 8.9% increase in June sales to $6.28 billion, compared to $5.77 billion for June 2013.

The retail drug store chain said total front end sales increased 1.8% year-over-year and comparable store front end sales grew 1.3% for June 2014.

Last month pharmacy sales increased 13.4%, and sales in comparable stores rose 7.5% in June 2014.

Must Read: Warren Buffett's 25 Favorite Stocks

Fiscal year-to-date sales for the first 10-months of 2014 were up 6% to $63.65 billion, compared to $36 billion in fiscal 2013.

Separately, TheStreet Ratings team rates WALGREEN CO as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:

"We rate WALGREEN CO (WAG) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

If you liked this article you might like

Cramer: Dominoes Are in Play Today

In Case You Missed It Weekend Edition: National Enquirer Trumps Energy Week

Former Walmart Exec Says Border Tax Opposed by Retailers Could Save Industry

Walgreen Looks Good However Rite-Aid Deal Pans Out